The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $64.71

Today's change-0.31 -0.48%
Updated March 29 3:11 PM EDT. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $64.71

Today's change-0.31 -0.48%
Updated March 29 3:11 PM EDT. Delayed by at least 15 minutes.

Neogen Corp down (U.S.)$0.31

Neogen Corp is lower today, dropping (U.S.)$0.31 or 0.48% to (U.S.)$64.71. Over the last five days, shares have gained 0.26%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 17.95% during the last year.

Key company metrics

  • Open(U.S.) $64.84
  • Previous close(U.S.) $65.02
  • High(U.S.) $64.90
  • Low(U.S.) $64.15
  • Bid / Ask(U.S.) $64.66 / (U.S.) $64.72
  • YTD % change-1.95%
  • Volume43,769
  • Average volume (10-day)172,216
  • Average volume (1-month)108,962
  • Average volume (3-month)125,771
  • 52-week range(U.S.) $44.44 to (U.S.) $69.09
  • Beta1.47
  • Trailing P/E60.07×
  • P/E 1 year forward57.12×
  • Forward PEG3.43×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.08
Updated March 29 3:11 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.32%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201702/28/2017Nov 30, 201611/30/2016Aug 31, 201608/31/2016May 31, 201605/31/2016
Revenue88918490
Total other revenue--------
Total revenue88918490
Gross profit41444042
Total cost of revenue48474348
Total operating expense74746974
Selling / general / administrative24242324
Research & development3332
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income14171516
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax16171515
Income after tax10111010
Income tax, total5655
Net income10111010
Total adjustments to net income--------
Net income before extra. items10111010
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items10111010
Inc. avail. to common incl. extra. items10111010
Diluted net income10111010
Dilution adjustment--------
Diluted weighted average shares39383838
Diluted EPS excluding extraordinary itemsvalue per share0.270.290.260.26
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.270.290.260.26